• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proc Natl Acad Sci U S A . Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A


. 2022 Aug 2;119(31):e2205412119.
doi: 10.1073/pnas.2205412119. Epub 2022 Jul 15.
Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes


Halina Mikolajek[SUP] 1 2 [/SUP], Miriam Weckener[SUP] 3 [/SUP], Z Faidon Brotzakis[SUP] 4 [/SUP], Jiandong Huo[SUP] 2 3 5 [/SUP], Evmorfia V Dalietou[SUP] 3 [/SUP], Audrey Le Bas[SUP] 2 3 [/SUP], Pietro Sormanni[SUP] 4 [/SUP], Peter J Harrison[SUP] 1 2 [/SUP], Philip N Ward[SUP] 2 3 [/SUP], Steven Truong[SUP] 4 [/SUP], Lucile Moynie[SUP] 2 3 [/SUP], Daniel K Clare[SUP] 1 [/SUP], Maud Dumoux[SUP] 2 3 [/SUP], Joshua Dormon[SUP] 2 3 [/SUP], Chelsea Norman[SUP] 2 3 [/SUP], Naveed Hussain[SUP] 2 3 5 6 [/SUP], Vinod Vogirala[SUP] 1 [/SUP], Raymond J Owens[SUP] 2 3 5 [/SUP], Michele Vendruscolo[SUP] 4 [/SUP], James H Naismith[SUP] 2 3 5 [/SUP]



Affiliations

Abstract

Camelid single-domain antibodies, also known as nanobodies, can be readily isolated from naïve libraries for specific targets but often bind too weakly to their targets to be immediately useful. Laboratory-based genetic engineering methods to enhance their affinity, termed maturation, can deliver useful reagents for different areas of biology and potentially medicine. Using the receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and a naïve library, we generated closely related nanobodies with micromolar to nanomolar binding affinities. By analyzing the structure-activity relationship using X-ray crystallography, cryoelectron microscopy, and biophysical methods, we observed that higher conformational entropy losses in the formation of the spike protein-nanobody complex are associated with tighter binding. To investigate this, we generated structural ensembles of the different complexes from electron microscopy maps and correlated the conformational fluctuations with binding affinity. This insight guided the engineering of a nanobody with improved affinity for the spike protein.

Keywords: COVID-19; affinity; biophysics; computational tool; electron microscopy.
 
Back
Top Bottom